Skip to content

A study of efficacy and safety of long-term intake of the test food on cognitive function

A randomized, double-blind, placebo-controlled parallel study to assess the efficacy and safety of long-term intake of the test food on cognitive function - A study of efficacy and safety of long-term intake of the test food on cognitive function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046973
Enrollment
40
Registered
2022-05-17
Start date
2022-05-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Oral intake of the test food (12 weeks) Oral intake of the placebo (12 weeks)

Sponsors

Momoya Co., Ltd.
Lead Sponsor
Kagawa Nutrition University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy males and females aged 20 to less than 75 years old. 2) Subjects who are capable of understanding the study, and those who can give written informed consents.

Exclusion criteria

Exclusion criteria: 1) Subjects who are allergic to products related to the test material of this study. 2) Subjects who are addicted to alcohol or has an extremely irregular dietary habit. 3) Subjects who take drugs, quasi-drugs, dietary supplements, health foods or something other which possibly have effects on this study. 4) Subjects who are judged to have dementia, those who are receiving treatment, medication, and lifestyle guidance from a doctor due to dementia, those who have received it in the past. 5) Subjects who are pregnant or breastfeeding, or desires to get pregnant during the study period. 6) Subjects who are judged unsuitable for this study by principal investigator.

Design outcomes

Primary

MeasureTime frame
Cognitive function test (Cognitrax)

Secondary

MeasureTime frame
Blood test Urinalysis Physical condition diary

Countries

Japan

Contacts

Public ContactYuko Nagata

Momoya Co., Ltd. Research & Development Division

y.nagata@momoya.co.jp048-720-8352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026